Thromb Haemost 2014; 112(04): 770-780
DOI: 10.1160/TH14-01-0043
Endothelium and Vascular Development
Schattauer GmbH

Isolation of a circulating CD45-, CD34dim cell population and validation of their endothelial phenotype

Margaret M. Tropea
1   Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA
,
Bonnie J. A. Harper
1   Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA
,
Grace M. Graninger
1   Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA
,
Terry M. Phillips
2   Ultramicro Analytical Immunochemistry Unit, Biomedical Engineering and Physical Science, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, USA
,
Gabriela Ferreyra
1   Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA
,
Howard S. Mostowski
4   Division of Cell and Gene Therapy, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA
,
Robert L. Danner
1   Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA
,
Anthony F. Suffredini
1   Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA
,
Michael A. Solomon
1   Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA
3   Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA
› Author Affiliations
Financial support: This work was funded by Critical Care Medicine Department, Clinical Center Intramural Research Program.
Further Information

Publication History

Received: 15 January 2014

Accepted after major revision: 14 May 2014

Publication Date:
21 November 2017 (online)

Summary

Accurately detecting circulating endothelial cells (CECs) is important since their enumeration has been proposed as a biomarker to measure injury to the vascular endothelium. However, there is no single methodology for determining CECs in blood, making comparison across studies difficult. Many methods for detecting CECs rely on characteristic cell surface markers and cell viability indicators, but lack secondary validation. Here, a CEC population in healthy adult human subjects was identified by flow cytometry as CD45-, CD34dim that is comparable to a previously described CD45-, CD31bright population. In addition, nuclear staining with 7-aminoactinomycin D (7-AAD) was employed as a standard technique to exclude dead cells. Unexpectedly, the CD45-, CD34dim, 7-AAD- CECs lacked surface detectable CD146, a commonly used marker of CECs. Furthermore, light microscopy revealed this cell population to be composed primarily of large cells without a clearly defined nucleus. Nevertheless, immunostains still demonstrated the presence of the lectin Ulex europaeus and von Willebrand factor. Ultramicro analytical immunochemistry assays for the endothelial cell proteins CD31, CD34, CD62E, CD105, CD141, CD144 and vWF indicated these cells possess an endothelial phenotype. However, only a small amount of RNA, which was mostly degraded, could be isolated from these cells. Thus the majority of CECs in healthy individuals as defined by CD45-, CD34dim, and 7-AAD- have shed their CD146 surface marker and are senescent cells without an identifiable nucleus and lacking RNA of sufficient quantity and quality for transcriptomal analysis. This study highlights the importance of secondary validation of CEC identification.

 
  • References

  • 1 Bouvier CA GE, Cintron JR. et al. Circulating Endothelium as an Indicator of Vascular Injury. Thromb Diath Haemorrh 1970; 40 Suppl 163-168.
  • 2 Hladovec JaR P.. Circulating Endothelial Cells Isolated Together with Platelets and the Experimental Modification of their counts in Rats. Thrombosis Res 1973; 3: 665-674.
  • 3 Hladovec J, Prerovsky I, Stanek V. et al. Circulating endothelial cells in acute myocardial infarction and angina pectoris. Klin Wochenschr 1978; 56: 1033-1036.
  • 4 George F, Poncelet P, Laurent JC. et al. Cytofluorometric detection of human endothelial cells in whole blood using S-Endo 1 monoclonal antibody. J Immunol Methods 1991; 139: 65-75.
  • 5 George F BC, Poncelet P. et al. Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty. Thromb Haemost 1992; 67: 147-153.
  • 6 Janssens D, Michiels C, Guillaume G. et al. Increase in circulating endothelial cells in patients with primary chronic venous insufficiency: protective effect of Ginkor Fort in a randomized double-blind, placebo-controlled clinical trial. J Cardiovasc Pharmacol 1999; 33: 7-11.
  • 7 Bertolini F, Shaked Y, Mancuso P. et al. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer 2006; 6: 835-845.
  • 8 Rowand JL, Martin G, Doyle GV. et al. Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas. Cytometry A 2007; 71: 105-113.
  • 9 Strijbos MH, Landburg PP, Nur E. et al. Circulating endothelial cells: a potential parameter of organ damage in sickle cell anemia?. Blood Cells Mol Dis 2009; 43: 63-67.
  • 10 Lombardo MF, Iacopino P, Cuzzola M. et al. Type 2 diabetes mellitus impairs the maturation of endothelial progenitor cells and increases the number of circulating endothelial cells in peripheral blood. Cytometry A 2012; 81: 856-864.
  • 11 Damani S, Bacconi A, Libiger O. et al. Characterization of circulating endothelial cells in acute myocardial infarction. Sci Transl Med 2012; 4: 126ra33.
  • 12 Tinazzi E, Dolcino M, Puccetti A. et al. Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by iloprost infusion. Arthritis Res Ther 2010; 12: R131.
  • 13 Rossi E, Fassan M, Aieta M. et al. Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer. Br J Cancer 2012; 107: 1286-1294.
  • 14 Manzoni M, Mariucci S, Delfanti S. et al. Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer. J Cancer Res Clin Oncol 2012; 138: 1187-1196.
  • 15 Jubb AM, Harris AL. Biomarkers to predict the clinical efficacy of bevacizumab in cancer. Lancet Oncol 2010; 11: 1172-1183.
  • 16 Erdbruegger U, Dhaygude A, Haubitz M. et al. Circulating endothelial cells: markers and mediators of vascular damage. Curr Stem Cell Res Ther 2010; 5: 294-302.
  • 17 Mancuso P, Antoniotti P, Quarna J. et al. Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses. Clin Cancer Res 2009; 15: 267-273.
  • 18 Elshal M, Abdelaziz A, Abbas A. et al. Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair. Nephrol Dial Transplant 2009; 24: 1495-1499.
  • 19 Woywodt A, Blann AD, Kirsch T. et al. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol. J Thromb Haemost 2006; 4: 671-677.
  • 20 Mariucci S, Rovati B, Chatzileontiadou S. et al. A six-colour flow cytometric method for simultaneous detection of cell phenotype and apoptosis of circulating endothelial cells. Scand J Clin Lab Invest 2009; 69: 433-438.
  • 21 Kraan J, Strijbos MH, Sieuwerts AM. et al. A new approach for rapid and reliable enumeration of circulating endothelial cells in patients. J Thromb Haemost 2012; 10: 931-939.
  • 22 Kraan J, Sleijfer S, Foekens JA. et al. Clinical value of circulating endothelial cell detection in oncology. Drug Discov Today 2012; 17: 710-717.
  • 23 Bardin VM, Moal V, Anfosso F, Daniel L, Brunet P, Sampol J, Dignat George F. Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration. Thromb Haemost 2003; 90: 915-920.
  • 24 Elshal MF, Khan SS, Takahashi Y. et al. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood 2005; 106: 2923-2924.
  • 25 Steurer M, Kern J, Zitt M. et al. Quantification of circulating endothelial and progenitor cells: comparison of quantitative PCR and four-channel flow cytometry. BMC Res Notes 2008; 1: 71.
  • 26 Duda DG, Cohen KS, Scadden DT. et al. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007; 2: 805-810.
  • 27 Strijbos M, Kraan J, den Bakker M. et al. Cells meeting our immunophenotypic criteria of endothelial cells are large platelets 3. Cytometry B Clin Cytom 2007; 72: 86-93.
  • 28 Duda DG, Cohen KS, di Tomaso E. et al. Differential CD146 Expression on Circulating Versus Tissue Endothelial Cells in Rectal Cancer Patients: Implications for Circulating Endothelial and Progenitor Cells As Biomarkers for Antiangiogenic Therapy. J Clin Oncol 2006; 24: 1449-1453.
  • 29 Phillips TM. Multi-analyte analysis of biological fluids with a recycling immunoaffinity column array. J Biochem Biophys Methods 2001; 49: 253-262.
  • 30 Ye J, Coulouris G, Zaretskaya I. et al. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 2012; 13: 134.
  • 31 Team RDC. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; Available at: http://www.R-project.org 2010. Accessed April 30, 2014.
  • 32 Newman PJ, Berndt MC, Gorski J. et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990; 247: 1219-1222.
  • 33 Strijbos MH, Kraan J, den Bakker MA. et al. Cells meeting our immunophenotypic criteria of endothelial cells are large platelets. Cytometry B Clin Cytom 2007; 72: 86-93.
  • 34 Mueller O, Lightfoot S, Schroder A. RNA Integrity Number (RIN) Standardization of RNA Quality Control. Tech Rep 5989-1165EN, Agilent Technologies, Application Note 2004.
  • 35 Bardin N, Anfosso F, Masse JM. et al. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 2001; 98: 3677-3684.
  • 36 Boneberg EM, Illges H, Legler DF. et al. Soluble CD146 is generated by ectodomain shedding of membrane CD146 in a calcium-induced, matrix metallopro-tease-dependent process. Microvasc Res 2009; 78: 325-331.
  • 37 Bardin N, Blot-Chabaud M, Despoix N. et al. CD146 and its Soluble Form Regulate Monocyte Transendothelial Migration. Arterioscler Thromb Vasc Biol 2009; 29: 746-753.
  • 38 Mund JA, Estes ML, Yoder MC. et al. Flow Cytometric Identification and Functional Characterization of Immature and Mature Circulating Endothelial Cells. Arterioscler Thromb Vasc Biol 2012; 32: 1045-1053.
  • 39 Yu H-K, Lee H-J, Choi H-N. et al. Characterization of CD45-/CD31+/CD105+ circulating cells in the peripheral blood of patients with gynecological malignancies. Clin Cancer Res 2013; 19: 5340-5350.
  • 40 Fadini GP, Losordo D, Dimmeler S. Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use. Circ Res 2012; 110: 624-637.
  • 41 Antonova OA, Loktionova SA, Romanov YA. et al. Activation and damage of endothelial cells upon hypoxia/reoxygenation. Effect of extracellular pH. Biochemistry 2009; 74: 605-612.
  • 42 Aoudjit F, Vuori K. Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikis. J Cell Biol 2001; 152: 633-643.
  • 43 Schmid I, Krall WJ, Uittenbogaart CH. et al. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 1992; 13: 204-208.
  • 44 Xu W, Boadle R, Dear L. et al. Ultrastructural Changes in Endothelium during Apoptosis Indicate Low Microembolic Potential. J Vasc Res 2005; 42: 377-387.